Ortivus appoints Gustaf Nordenhök as new CEO

We are happy to announce the recruitment of Gustaf Nordenhök as Ortivus' new Chief Executive Officer and as a member of the management team. Gustaf assumes the position of CEO on January 1, and the outgoing CEO, Reidar Gårdebäck, will remain with the company until March 31, 2024.

As previously communicated, Ortivus’ CEO and president Reidar Gårdebäck has decided to leave the company after nearly 5 years of service. The Board has now recruited Gustaf Nordenhök as the new CEO of the company and the group.

Gustaf Nordenhök has extensive experience working as a CEO as well as sales and development manager of medical technology products and solutions both in Sweden and internationally. He has, among other roles, close to 10 years of experience in selling SaaS solutions within the alarm services sector.

“We are delighted to welcome Gustaf Nordenhök to Ortivus. His extensive experience in selling IT systems to the healthcare sector, both in Sweden and internationally, will contribute to the continued growth of the company. We would also like to express our gratitude to Reidar Gårdebäck for the past years. Under Reidars' leadership, Ortivus has undergone significant development, introducing new solutions, forming partnerships, and expanding the company’s international presence." says Anders Paulsson, Chairman of the Board for Ortivus.

Reidar Gårdebäck will, during the period leading up to March 31, 2024, focus on a good transition.

For further information, please contact:

Anders Paulsson, Chairman of the Board
Email: paulsson.anders@me.com

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, – an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, – a tool for navigation and case management, and MobiMed Life – a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com